TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding
Nina Dedic(Chugai Pharma (United States)), Kenneth S. Koblan(Sumitomo Dainippon Pharma (United States))
Cited by 20
Related Papers
SKA2 regulated hyperactive secretory autophagy drives neuroinflammation-induced neurodegeneration
|Nature Communications|2024|30
SKA2 regulated hyperactive secretory autophagy drives neuroinflammation-induced neurodegeneration
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0